Cargando…

Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells

Natural killer (NK) cells are critical innate immune lymphocytes capable of destroying virally infected or cancerous cells through targeted cytotoxicity and further assisting in the immune response by releasing inflammatory cytokines. NK cells are thought to contribute to the process of tumor killin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mentlik James, Ashley, Cohen, Adam D., Campbell, Kerry S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870292/ https://www.ncbi.nlm.nih.gov/pubmed/24391651 http://dx.doi.org/10.3389/fimmu.2013.00481

Ejemplares similares

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
por: Campbell, Kerry S., et al.
Publicado: (2018)

Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
por: dos Reis, Filipa D., et al.
Publicado: (2023)

NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions
por: Luo, Heyong, et al.
Publicado: (2023)

Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice
por: Kaur, Kawaljit, et al.
Publicado: (2023)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells
por: Guimont-Desrochers, Fanny, et al.
Publicado: (2013)

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
por: Tomalka, Amanda G., et al.
Publicado: (2018)

Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity
por: Wu, Ying, et al.
Publicado: (2022)

The Ultimate Goal of Curative Anti-Cancer Therapies: Inducing an Adaptive Anti-Tumor Immune Response
por: Fridman, Wolf H., et al.
Publicado: (2011)

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
por: Valeri, Antonio, et al.
Publicado: (2022)

NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
por: Russo, Eleonora, et al.
Publicado: (2021)

The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection
por: Ochayon, David E., et al.
Publicado: (2021)

Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2023)

The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
por: Wu, Zhengguo, et al.
Publicado: (2021)

Combination of verteporfin-photodynamic therapy with 5-aza-2’-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer
por: Banerjee, Shramana M., et al.
Publicado: (2023)

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
por: Willebrand, Ralf, et al.
Publicado: (2019)

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
por: Chretien, Anne-Sophie, et al.
Publicado: (2014)

STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity
por: Meissl, Katrin, et al.
Publicado: (2020)

HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
por: Duygu, Burcu, et al.
Publicado: (2021)

Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas
por: Zuo, Pengcheng, et al.
Publicado: (2023)

Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity
por: Donnenberg, Vera S., et al.
Publicado: (2022)

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat
por: Afolabi, Lukman O., et al.
Publicado: (2021)

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
por: Seliger, Barbara
Publicado: (2019)

Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy
por: Yang, Kangdi, et al.
Publicado: (2023)

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

NK cell exhaustion in the tumor microenvironment
por: Jia, Hao, et al.
Publicado: (2023)

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
por: Zheng, Weiwei, et al.
Publicado: (2022)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
por: Zappasodi, Roberta, et al.
Publicado: (2022)

NK Cell-Based Immune Checkpoint Inhibition
por: Khan, Muhammad, et al.
Publicado: (2020)

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model
por: Veinalde, Rūta, et al.
Publicado: (2023)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
por: Shin, Eunju, et al.
Publicado: (2023)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
por: Redmond, William L., et al.
Publicado: (2023)

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2023)

NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses
por: Mensching, Leonore, et al.
Publicado: (2022)

The Adverse Impact of Tumor Microenvironment on NK-Cell
por: Hu, Ziming, et al.
Publicado: (2021)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2(+) Murine Neuroblastoma
por: Bates, Paul D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tarld0an51hfam5o0unmmgv189